about
Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus.First-in-humans study of the safety, tolerability, and pharmacokinetics of ACT-451840, a new chemical entity with antimalarial activity.Assessment of lopinavir pharmacokinetics with respect to developmental changes in infants and the impact on weight band-based dosing.Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug SolubilizationAnalgesic Activity of Tramadol and Buprenorphine after Voluntary Ingestion by Rats (Rattus norvegicus).Physiological factors in drug absorption.Oral bioavailability: issues and solutions via nanoformulations.Single-dose pharmacokinetics of indinavir and the effect of food.Single-dose safety, pharmacokinetics, and food effects studies of compound naphthoquine phosphate tablets in healthy volunteers.Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects.Pharmacokinetic studies in healthy volunteers in the context of in vitro/in vivo correlations.Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes.Pharmacokinetics of ganoderic acids a and f after oral administration of ling zhi preparation in healthy male volunteers.Effects of a non-absorbable osmotic load on drug absorption in healthy volunteers.Clinical trial simulation to evaluate population pharmacokinetics and food effect: capturing abiraterone and nilotinib exposures.Diseases and drugs but not food decrease ketoconazole 'bioavailability'.The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients.The effect of soybean oil refuse powder used as vehicle on the absorption of oxolinic acid in chickens under fasting and nonfasting conditions and the correlation with in vitro dissolution.Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption.The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics.Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteers.Influence of food on the gastric motor effect of the Kampo medicine rikkunshito in rat.Effect of food or proton pump inhibitor treatment on the bioavailability of dacomitinib in healthy volunteers.Effect of meal and antisecretory agents on the pharmacokinetics of danoprevir/ritonavir in healthy volunteers.Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies.The anthelmintic efficacy of papaya latex in a rodent-nematode model is not dependent on fasting before treatment.Bioavailability of amprolium in fasting and nonfasting chickens after intravenous and oral administration.Influence of food on the absorption of beta-methyldigoxin.Influence of food on the oral absorption and bioavailability of moricizine.Effect of food on the pharmacokinetics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, and assessment of dose proportionality in healthy participants.Interaction of meloxicam with cimetidine, Maalox, or aspirin.
P2860
Q34398484-C29951EF-831D-41AD-B22C-861C6400DE8AQ35105980-24541A27-6A3F-497B-96BC-BF5F9BF0DE18Q35973937-14D0F43E-0C6D-44F9-8335-09DADC02D3A2Q36446679-64D84E3D-BA40-47CD-BAD2-F4320B7FA819Q36561149-B7BCD7BB-3690-45DC-A4CC-BE0C676B69D5Q37672738-E5F36B95-7C13-4340-8F67-DF3C54830C38Q38349734-6D672DE0-2FC1-4AF5-A331-C022A73D2974Q39556676-D1A35D2B-FD6B-4629-8C87-D152E265285AQ39895765-239016C1-1966-42A6-ADC1-7263D2256059Q40334467-E7808518-A3CD-4F29-9131-EF4DBF5E2DB8Q40827237-96658FEA-011F-4CAB-9ED3-1B34CC369A20Q41201713-935824FD-B771-4A8A-99B3-CE102CF2A4F1Q41876949-9A5E94E4-3452-43CB-A7D1-2C5C85ABC3ABQ42092581-6BA6F822-66EA-4F5C-9C91-9A289378ABF4Q42109132-19D66131-5DAA-409D-A69A-677FA9BE552BQ43222934-D8FFFD6C-91F3-4FB6-B559-23C401C05045Q43224332-25A26AE4-10F9-4D49-9655-E61B94069C26Q43790389-CAF2FC5A-C3C1-482F-B817-E7CD60309D39Q46349067-19B2F6A1-AC60-4076-B73C-C86CB80E30D5Q46516849-6B36462E-3C91-4281-9F03-6D4C1E92FCA9Q46974104-9A3AB428-2CB1-4640-9CA3-1B51C41A66B7Q48056563-F846BC33-D713-4C6A-A627-92FEF1A722EEQ51299907-04796BAB-BD55-49D0-8FFA-F13868CDB3D1Q51332911-8E563265-3EDC-4D9A-B317-ADA0F98200BCQ51334594-8FD315F0-BF05-4E70-A88B-42B74BE288C8Q51370248-EE062F06-2297-4B15-96AA-3976F4883506Q51557302-63B67145-7128-4CC5-B935-08AF83241A3FQ51606884-0A2E7C4C-8D77-4276-BA92-DE9909B63549Q51609378-8A65EDF7-6D31-4B83-A4A0-6F13A94AF950Q53109271-03E88AC3-1171-4991-8542-75A8C98E8642Q53994014-C0AD6441-CB1A-4C8B-8A02-04128343199C
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
The effects of food on drug bioavailability.
@en
type
label
The effects of food on drug bioavailability.
@en
prefLabel
The effects of food on drug bioavailability.
@en
P2860
P1476
The effects of food on drug bioavailability.
@en
P2093
Winstanley PA
P2860
P304
P356
10.1111/J.1365-2125.1989.TB03554.X
P407
P577
1989-12-01T00:00:00Z